NCT00154414
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Tokyo, Japan
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
7,994 public trials
713 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT03030300
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Shandong Provincial Hospital Jinan, Shandong, China
- Qianfoshan Hospital Jinan, Shandong, China
- Qilu Hospital Jinan, Shandong, China
NCT00318422
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Buenos Aires, Argentina
- Novo Nordisk Investigational Site Buenos Aires, Argentina
- Novo Nordisk Investigational Site Buenos Aires, Argentina
- Novo Nordisk Investigational Site Córdoba, Argentina
Completed
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
NCT02336945
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Unger Primary Care Medical Center & Catalina Research Institute Chino, California, United States
- Dr. Deanna Cheung Long Beach, California, United States
- University of California San Diego Veterns Affairs Medical Center San Diego, California, United States
- Henry Ford Medical Center Detroit, Michigan, United States
Completed
Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes
NCT01508923
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Århus C, Denmark
NCT00133718
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +12 more
- Locations
-
- Asker and Baerum Hospital, Medical Department Rud, Norway
Completed
Metformin Extended Release Versus Metformin Immediate Release in Subjects With Type 2 Diabetes
NCT02252965
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Please contact the Merck KGaA Communication Center Darmstadt, Germany
NCT01508806
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Christchurch, Australia
NCT01620463
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Tokyo, Japan
Completed
Evaluate the Pharmacokinetics of Warfarin When Coadministered With PEX168 in Healthy Adult Subjects
NCT02461914
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
Not specified